VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 90 filers reported holding VYNE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $73 | -99.8% | 488,012 | +145.6% | 0.00% | – |
Q3 2022 | $44,000 | -31.2% | 198,714 | +20.9% | 0.00% | – |
Q2 2022 | $64,000 | -72.2% | 164,415 | -53.6% | 0.00% | – |
Q1 2022 | $230,000 | -47.7% | 354,001 | -18.0% | 0.00% | – |
Q4 2021 | $440,000 | -26.8% | 431,485 | -0.2% | 0.00% | – |
Q3 2021 | $601,000 | -74.8% | 432,424 | -36.3% | 0.00% | -100.0% |
Q2 2021 | $2,384,000 | +1239.3% | 679,211 | +2513.0% | 0.00% | – |
Q1 2021 | $178,000 | – | 25,994 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,100,000 | $1,529,000 | 1.55% |
Healthcare Value Capital, LLC | 400,000 | $556,000 | 1.10% |
CM Management, LLC | 143,750 | $200,000 | 0.15% |
Perceptive Advisors | 2,330,471 | $3,239,000 | 0.05% |
683 Capital Management, LLC | 715,386 | $994,000 | 0.04% |
Virtu Financial LLC | 108,319 | $151,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 92,402 | $128,000 | 0.01% |
Platform Technology Partners | 14,457 | $20,000 | 0.01% |
Tekla Capital Management LLC | 135,395 | $188,000 | 0.01% |
DELTEC ASSET MANAGEMENT LLC | 30,000 | $42,000 | 0.01% |